leucovorin calcium / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 424 Diseases   807 Trials   807 Trials   14372 News 


«12...210211212213214215216217218219220...235236»
  • ||||||||||  Erbitux (cetuximab) / Eli Lilly
    Trial primary completion date, Metastases:  Nordic 8 - A Phase II Trial (clinicaltrials.gov) -  Jan 22, 2015   
    P2,  N=180, Recruiting, 
    Recruiting --> Active, not recruiting Trial primary completion date: Sep 2014 --> Dec 2016
  • ||||||||||  enoxaparin sodium / Generic mfg.
    Enrollment change:  Chemotherapy With or Without Enoxaparin in Pancreatic Cancer (clinicaltrials.gov) -  Jan 8, 2015   
    P2/3,  N=312, Completed, 
    N=25 --> 1 | Active, not recruiting --> Terminated | Trial primary completion date: Oct 2017 --> Dec 2014; Slow accrual. N=540 --> 312
  • ||||||||||  saridegib oral (IPI 926 oral) / Infinity Pharma
    Enrollment open, Trial initiation date, Trial primary completion date, Metastases:  FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma (clinicaltrials.gov) -  Jan 2, 2015   
    P1,  N=21, Recruiting, 
    Trial primary completion date: Jan 2015 --> Jan 2017 Active, not recruiting --> Recruiting | Initiation date: Aug 2011 --> Nov 2014 | Trial primary completion date: Apr 2013 --> Nov 2017
  • ||||||||||  dilpacimab (ABT-165) / AbbVie
    Enrollment open, Metastases:  A Study of ABT-165 in Subjects With Solid Tumors (clinicaltrials.gov) -  Dec 24, 2014   
    P1,  N=75, Recruiting, 
    N=1680 --> 610 Suspended --> Recruiting
  • ||||||||||  Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
    Enrollment open, Metastases:  MATEO: Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer (clinicaltrials.gov) -  Dec 19, 2014   
    P2,  N=400, Recruiting, 
    N=40 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Jun 2016 --> Nov 2014 Not yet recruiting --> Recruiting